| A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy (NCT05646862) | Hoffmann-La Roche | 2023-06-07 |
| Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening (NCT05665660) | Johns Hopkins Bloomberg School of Public Health | 2023-06-06 |
| A French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Biopsy. (NCT06024213) | BTG International Inc. | 2023-06-06 |
| Tumor-Derived FGF19 (NCT06068257) | University of Central Florida | 2023-06-06 |
| Homologous Recombination Repair Pathway Gene Mutation Spectrum in Chinese Breast Cancer Patients (NCT05901025) | Shanghai Jiao Tong University School of Medicine | 2023-06-05 |
| Safe De-escalation of Chemotherapy for Stage 1 Breast Cancer (NCT05058183) | Royal Marsden NHS Foundation Trust | 2023-06-05 |
| Disitamab Vedotin (RC48-ADC) in Breast Cancer (NCT05851677) | RenJi Hospital | 2023-06-01 |
| Diagnostic Performance of Breast Cancer Screening Second Reading Process Assisted by AI (NCT05800132) | Therapixel | 2023-06-01 |
| MRD in High-risk EBC (NCT06566729) | Shanghai Jiao Tong University School of Medicine | 2023-06-01 |
| Muscle Energy Technique and Mulligan's Mobilization in Breast Cancer Surgery Patients (NCT05911867) | Cairo University | 2023-06-01 |
| Role of Irisin/FNDC5 (rs3480) Single Nucleotide Polymorphism in Breast Cancer (NCT05876728) | Sohag University | 2023-06-01 |
| A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer (NCT06938711) | Context Therapeutics Inc. | 2023-06-01 |
| Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery (NCT06595966) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-06-01 |
| Effect of Kefir on Symptom Management and Quality of Life in Oncology (NCT06517420) | Izmir Bakircay University | 2023-06-01 |
| Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC) (NCT05722795) | Vastra Gotaland Region | 2023-06-01 |
| Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01) (NCT05891093) | Fudan University | 2023-06-01 |
| Clinical Validation of Radiomics Artificial Intelligence: Application to Breast Cancer Treatment Planning (NCT05070884) | Instituto de Investigacion Sanitaria La Fe | 2023-06-01 |
| Hand-Foot Exercises on Peripheral Neuropathy (NCT06055088) | Amasya University | 2023-06-01 |
| ONCOlogy-targeted NLP-powered Federated Hyper-archItecture and Data Sharing Framework for Health Data Reusability (NCT05060835) | Instituto de Investigacion Sanitaria La Fe | 2023-06-01 |
| Treatment of Insomnia in Patients With Breast Cancer (NCT06061666) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2023-06-01 |
| A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors (NCT05864144) | Sensei Biotherapeutics, Inc. | 2023-05-31 |
| Different Localization Techniques for Non-palpable Breast Lesions Comparison: a Retrospective and Multicentric Clinical Study (NCT05942105) | Istituti Clinici Scientifici Maugeri SpA | 2023-05-31 |
| Comparison Between ROLL Versus Magnetic Seed for Preoperative Localization of Non-palpable Breast Lesion by Randomized Clinical Study. (NCT05942118) | Istituti Clinici Scientifici Maugeri SpA | 2023-05-31 |
| Adapting the Tumor Board Model for Mental Illness and Cancer (NCT05837598) | Massachusetts General Hospital | 2023-05-31 |
| HER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in Russia (NCT05905939) | AstraZeneca | 2023-05-31 |
| HER2-low Unresectable and/or Metastatic Breast Cancer in Russia (NCT05913440) | AstraZeneca | 2023-05-30 |
| Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer (NCT05673629) | Beijing Biostar Pharmaceuticals Co., Ltd. | 2023-05-30 |
| A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN) (NCT06028724) | Centro di Riferimento Oncologico - Aviano | 2023-05-26 |
| Preoperative Boost Associated With Neoadjuvant Chemotherapy in Luminal B Breast Cancer (NCT05673304) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2023-05-24 |
| Rehabilitation on Equal Terms - The ReMig Study (NCT05689398) | Lund University | 2023-05-24 |
| PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin (NCT05810870) | MedSIR | 2023-05-24 |
| A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC) (NCT05675579) | M.D. Anderson Cancer Center | 2023-05-23 |
| Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep Quality (NCT05732064) | Peking University First Hospital | 2023-05-22 |
| Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors. (NCT05878964) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2023-05-22 |
| Achieving Equity in Genomic Testing for Breast Cancer Through Partner-Led Strategies and Policies (NCT05916378) | Stanford University | 2023-05-22 |
| Initial CDK 4/6 Inhibitor Plus Endocrine Therapy Versus Initial Chemotherapy in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer (NCT06344793) | Fudan University | 2023-05-20 |
| EXERT-BCN: an Exercise and Nutrition Regimen to Designed to Improve Body Composition After Treatment for Breast Cancer (NCT05978960) | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 2023-05-20 |
| Abemaciclib, Palbociclib or Dalpiciclib Combined with Endocrine Therapy As First-line Treatment in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer (NCT06344780) | Fudan University | 2023-05-20 |
| Overcoming Therapy Resistance in ER+ Breast Cancer Patients: a Translational Project (OVERTuRE) (NCT06129786) | Centro di Riferimento Oncologico - Aviano | 2023-05-18 |
| Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer (NCT07021911) | Fondazione Policlinico Universitario Campus Bio-Medico | 2023-05-17 |
| Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy (NCT06161233) | Istituti Clinici Scientifici Maugeri SpA | 2023-05-16 |
| Personalized Estimation of Doses Delivered During Image Guided Radiation Therapy Tests (NCT05258383) | Assistance Publique - Hôpitaux de Paris | 2023-05-15 |
| Magnetic Resonance Imaging in Radiotherapy for Breast Cancer (NCT05902507) | University of California, San Francisco | 2023-05-15 |
| Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial (NCT05763992) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-05-15 |
| Prospective Study of Particle Radiotherapy for Breast Cancer With Different Arm Position (NCT05878678) | Shanghai Proton and Heavy Ion Center | 2023-05-15 |
| Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M) (NCT05907681) | Samsung Medical Center | 2023-05-11 |
| Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial) (NCT05716542) | Washington University School of Medicine | 2023-05-11 |
| A Study of Neoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast Cancer (NCT06000917) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2023-05-11 |
| The Effect of Mindfulness-based Yoga and Meditation on Some Parameters in Breast Cancer Patients (NCT06110832) | Kutahya Health Sciences University | 2023-05-11 |
| Mammogram Mail- and Phone-based Interventions (NCT05853848) | Geisinger Clinic | 2023-05-10 |
| Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients (NCT06622954) | Erasmus Medical Center | 2023-05-10 |
| Adaptive Symptom Self-Management Immunotherapy Study (NCT05715255) | University of Arizona | 2023-05-08 |
| Robotic vs. Open NSM for Early Stage Breast Cancer (NCT05720039) | Intuitive Surgical | 2023-05-08 |
| Non-contrast Magnetic Resonance Angiography in Deep Inferior Epigastric Perforator Flap Breast Reconstruction Planning (NCT06061835) | I.M. Sechenov First Moscow State Medical University | 2023-05-06 |
| Adjuvant Study of Pyrotinib in Combination With Trastuzumab in HER2 Positive Invasive Breast Cancer (NCT05841381) | Fudan University | 2023-05-06 |
| Assessment of Cryotherapy's Analgesic Impact in Anti-aromatase-induced Arthralgia (NCT05315011) | University Hospital, Montpellier | 2023-05-05 |
| TRUDI: TDXD+Durva in HER2+/Low IBC (NCT05795101) | Filipa Lynce, MD | 2023-05-04 |
| Correlation of Timing of Pegfilgrastim Administration and PIBP. (NCT05841186) | Guangdong Provincial People's Hospital | 2023-05-04 |
| Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study (NCT06464341) | University Hospital, Basel, Switzerland | 2023-05-04 |
| Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC (NCT05918328) | Henan Cancer Hospital | 2023-05-03 |
| FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments (NCT05810025) | Columbia University | 2023-05-01 |
| Dalpiciclib Plus Fulvestrant With Pyrotinib in Hormone Receptor-positive, HER2-low Advanced Breast Cancer That Progressed on Previous CDK4/6i Plus AI Therapy (NCT05806671) | Tianjin Medical University Cancer Institute and Hospital | 2023-05-01 |
| Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer (NCT07018427) | Peking University Cancer Hospital & Institute | 2023-05-01 |
| Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study (NCT06805812) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-05-01 |
| EvaLuating negAtive pressUre Wound theRapy in brEast coNserving Surgery (NCT05509829) | Zuyderland Medisch Centrum | 2023-05-01 |
| Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy (NCT05790096) | Blau Farmaceutica S.A. | 2023-05-01 |
| Evaluation of the Bexa™ Breast Examination (BBE) (NCT05882019) | Sure, Inc. | 2023-05-01 |
| Implantable Microdevice for TNBC - Pilot Study (NCT05774886) | Dana-Farber Cancer Institute | 2023-05-01 |
| CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer (NCT05795335) | RenJi Hospital | 2023-04-30 |
| A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors (NCT05784597) | Philogen S.p.A. | 2023-04-27 |
| Exercise in Metastatic Breast Cancer: EMBody (NCT05468034) | Indiana University | 2023-04-26 |
| ROLL Versus Magnetic Seed for Preoperative Localization of Non-palpable Breast Lesion: Comparison Between Techniques. (NCT05942092) | Istituti Clinici Scientifici Maugeri SpA | 2023-04-26 |
| A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors (NCT06508307) | GONGCHU Biotechnology Co., Ltd | 2023-04-26 |
| Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ) (NCT05269160) | Baylor College of Medicine | 2023-04-24 |
| Comparison of Ultrasound and Breast MRI for Breast Cancer Detection (NCT05797545) | Samsung Medical Center | 2023-04-23 |
| Awareness Scale Related To Physiotherapy After Breast Cancer: A Scale Development Study (NCT05992441) | Fenerbahce University | 2023-04-23 |
| Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials (NCT05146297) | Icahn School of Medicine at Mount Sinai | 2023-04-23 |
| Impact of Topical Tranexamic Acid in Breast Reconstruction (NCT05807074) | University of California, San Francisco | 2023-04-20 |
| The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia (NCT06236373) | University of Modena and Reggio Emilia | 2023-04-20 |
| STOP-HER2: Stopping Trastuzumab in HER2+ MBC (NCT05721248) | Dana-Farber Cancer Institute | 2023-04-19 |
| A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors (NCT05787587) | IDEAYA Biosciences | 2023-04-18 |
| Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer (NCT05020860) | Baylor Breast Care Center | 2023-04-18 |
| A Phase I Study of RGT-419B in Patients With HR-Positive, HER2-Negative Advanced Breast Cancer or Other Solid Tumors (NCT06299124) | Regor Pharmaceuticals Inc. | 2023-04-17 |
| First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors (NCT05768139) | Eli Lilly and Company | 2023-04-17 |
| Clinical Study of Pyrotinib in Neoadjuvant Therapy of HR-positive and HER2-positive Breast Cancer (NCT05430347) | The First Affiliated Hospital with Nanjing Medical University | 2023-04-15 |
| Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention (NCT05677048) | M.D. Anderson Cancer Center | 2023-04-14 |
| ICG and SLN Mapping (NCT05859971) | University of Wisconsin, Madison | 2023-04-13 |
| A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania (NCT05438511) | Memorial Sloan Kettering Cancer Center | 2023-04-13 |
| Managing Breast Cancer Treatment: Dyad's Perspectives on Treatment Decision, Financial and Family Burden. (NCT05917444) | National Taiwan University Hospital | 2023-04-12 |
| Mechanism Exploration of Anti-HER-2 Small-molecule Tyrosine Kinase Inhibitor-related Diarrhea and Establishment of Prevention and Treatment Model(Measure) (NCT05773391) | Sun Yat-sen University | 2023-04-12 |
| Exploring a Breast Cancer Early Screening Model Based on cfDNA (NCT06016790) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-04-11 |
| Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients (NCT06009627) | Tianjin Medical University Cancer Institute and Hospital | 2023-04-11 |
| Brain Metastasis Development Mechanism in BCBM Patients (NCT06330870) | Samsung Medical Center | 2023-04-06 |
| Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy With Immediate Autologous Breast Reconstruction With Integrated Nanomechanical Biomarker Evaluation (NCT05774678) | M.D. Anderson Cancer Center | 2023-04-05 |
| Experimental Study With Pretest/Posttest Groups Which the Intervention Group Have the System Which Sends Reminder Notifications Directing Them to the Website Containing BSE Training Along With the Illustrations Created for the Practice Prepared by the Researcher on the Determined Ideal Day (NCT05995483) | Eastern Mediterranean University | 2023-04-04 |
| Trial to Compare MRI-guided Precision Prone Irradiation (PPI) Versus CT-guided Breast Irradiation (NCT05731791) | Weill Medical College of Cornell University | 2023-04-03 |
| Comparison of AT & PR Training to Improve Functional Ability After Breast Cancer Surgery (NCT05873036) | Superior University | 2023-04-01 |
| Catheter Guided Chemo-infusion in Breast Cancer (NCT05661656) | Assiut University | 2023-04-01 |
| Cognitive Processing Slowness as a Marker of Cognitive Impairment in Non-central Nervous System Cancer Patients (NCT05754060) | Assistance Publique - Hôpitaux de Paris | 2023-04-01 |
| Examination of the Effect of Counselling and Follow-up After Breast Cancer Awareness Education (NCT06005025) | Tarsus University | 2023-04-01 |